Analysed OCULIS HOLDING AG (OCS:NASDAQ) News Sources
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
10-08-2026
yahoo.com
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
14-08-2026
yahoo.com
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
24-08-2026
yahoo.com
Wall Street Analysts Believe Oculis Holding AG (OCS) Could Rally 199.75%: Here's is How to Trade
31-08-2026
yahoo.com
After Plunging 24% in 4 Weeks, Here's Why the Trend Might Reverse for Oculis Holding AG (OCS)
28-09-2026
yahoo.com
What is the current price of OCULIS HOLDING AG (OCS:NASDAQ)?
The current price of OCULIS HOLDING AG (OCS:NASDAQ) is $8.34.
OCULIS HOLDING AG (OCS:NASDAQ) absolute price change since previous trading day?
The absolute price change of OCULIS HOLDING AG (OCS:NASDAQ) since the previous trading day is $-0.32.
OCULIS HOLDING AG (OCS:NASDAQ) percentage price change since previous trading day?
The percentage price change of OCULIS HOLDING AG (OCS:NASDAQ) since the previous trading day is -3.6952%.
What is the most recent average sentiment score for OCULIS HOLDING AG (OCS:NASDAQ)?
The most recent average sentiment score for OCULIS HOLDING AG (OCS:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for OCULIS HOLDING AG (OCS:NASDAQ)?
The most recent sentiment for OCULIS HOLDING AG (OCS:NASDAQ) is .
SEC-8K** Filing Available For OCULIS HOLDING AG (OCS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.